Khan, S., von Itzstein, M. S., Lu, R., Bermas, B. L., Karp, D. R., Khan, S. A., . . . Gerber, D. E. (2020). Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon. Oncologist.
Citación estilo ChicagoKhan, Shaheen, et al. "Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon." Oncologist 2020.
Cita MLAKhan, Shaheen, et al. "Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon." Oncologist 2020.
Precaución: Estas citas no son 100% exactas.